chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I was okay with the first dose; mild arm soreness, and mild flu-like symptoms later that evening (achiness, mild headache)--synptoms mostly cleared by the next day. The second dose, however, sparked an 8-day-long migraine that was so intense that I had to call out of work for several days and work lightly from home the rest of the time out of necessity. I was vomiting from the pain, hiding in my darkened bedroom in tears for days on end, and by days 4-5 I was scheduling massages and other therapies out of sheer desperation, looking for anything that would help. I have never, ever had a migraine last that long, or maintain such intensity for such a long period of time with no relief. Over-the-counter pain medications had no effect, and I lost approx. 5-6 lbs in 7 days due to an inability to keep food down. I will never forget waking up on Day 9 realizing for the first time in what felt like an eternity, that the pain had finally subsided. I felt hungover that day, as though I'd had been drinking the night before; nauseous, clouded/impaired cognitive function, sore muscles as though I'd been working out; but the migraine was finally gone. So far I have been too terrified of a repeat episode to get a booster shot.
Per patient his rheumatoid arthritis exacerbate. Pain is worst all over after his second moderna shot.
5JAN94 high pitched cry for hrs, accompanied by temp of 104 ax described tonic, clonic episode;
Seen 11/14/07 for fever that began about 8-9 pm. Fever in office 102.8. No URI symptoms. No local reaction to vaccine. On Bactrim for suspected UTI from 11/6/07. Left office had a febrile seizure. Sent to ER and had lumbar puncture, blood culture and labs.
Got call on 1/10/03 from ER. Succumbed to SIDS.
COVID 19 Treatment; COVID 19 Treatment; Rebound of symptoms; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 53-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 01Apr2021 as dose 1, single (Lot number: ER8737), in right arm, on 22Apr2021 as dose 2, single (Lot number: EW0172), in right arm and on 22Nov2021 as dose 3 (booster), single (Lot number: 30155BA), in right arm for covid-19 immunisation. The patient's relevant medical history included: "asthma" (unspecified if ongoing); "post herpetic neuralgia" (unspecified if ongoing). Concomitant medication(s) included: BREO ELLIPTA; MONTELUKAST, reported as patient also received other medication in 2weeks. The following information was reported: DISEASE RECURRENCE (medically significant) with onset 2022, outcome "not recovered", described as "Rebound of symptoms"; VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of vaccination failure, covid-19 included Paxlovid (lot number: 2815225) started on 15Aug2022 and stopped on 19Aug2022. Clinical course was reported as, Rebound of symptoms included severe cough, phlem, shortness of breath, right kidney pain, fever.
pt recvd vax & devel fever of 105; apap given; fever persisted 102-104; taken to hosp; meds given; t nl 13sep94;
Fever of 104 on 11/15/2007, white blisters on tongue. Medicated with infant Tylenol drops without a decrease in temperature.  Medicated with Ibuprofen 1.8ML with fever reducing to 102 on day 2 of vaccinations.
10/19/05 25 cent red area around injection site of left leg. 10/20/05 25 cent red area with itching 10/21/05 6" x 4" red,hot area,sent to ER by HD staff. Dx was allergic reaction local infection. Treated with Keflex, prednizone, benadryl. 10/24/05 area pink same size.
pt recv vax 3NOV95 & pt devel chicken pox consisting of approx 1000 lesions;pt also exp fever the first day a/the full breakout;dx of varicella was confirmed by MD during an office visit;
Parent of child called 7/29/11 AM. Reported child c/o chills & aches approx 6-8 hours after vaccine given. To bed early. Woke during noc, with headache & emesis x1. Reported feeling better this AM.
right arm extremely swollen; right arm really sore; felt really tired, need to go to bed; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (right arm really sore), FATIGUE (felt really tired, need to go to bed) and VACCINATION SITE SWELLING (right arm extremely swollen) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure abnormal and Allergy.   On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Feb-2021, the patient experienced VACCINATION SITE PAIN (right arm really sore) and FATIGUE (felt really tired, need to go to bed). On 01-Mar-2021, the patient experienced VACCINATION SITE SWELLING (right arm extremely swollen). The patient was treated with IBUPROFEN at a dose of 1 dosage form twice a day. At the time of the report, VACCINATION SITE PAIN (right arm really sore), FATIGUE (felt really tired, need to go to bed) and VACCINATION SITE SWELLING (right arm extremely swollen) outcome was unknown.            no concomitant medications are provided. Action taken with mRNA-1273 in response to the event was not applicable
This spontaneous report as received from a company representative refers to unknown number of patients. On an unknown date the patient(s) were vaccinated with VAQTA for prophylaxis. Lot# not provided. The field representative reported that an unspecified physician reported to him that their VAQTA had expired and was administered. He had questioned whether this was okay. The field representative stated he did not hear of any adverse effects. No other additional information was provided. Additional information has been requested.
Parent reports that pt began having difficulty breathing in evening of immunization, became pale, also developed fever that night - was taken to Snowcreek ER clinic next day - treated with nebulizer. parent did not tell MD of immunizations the day before.
Got mine in 94 spent week in bed never again; Initial information received on 29-Nov-2021 regarding an unsolicited valid social media non-serious case received from a consumer or non-healthcare professional via Global Digital Media.  This case involves adult patient who had got mine in 94 spent week in bed never again (bed rest) after receiving INFLUENZA VACCINE.  It was unknown if the patient had any medical history, concomitant disease or risk factor.  The patient's medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer [lot number and expiry date not reported] via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date the patient developed a non-serious got mine in 94 spent week in bed never again (bed rest) (unknown latency) following the administration of INFLUENZA VACCINE.   It was unknown if the patient experienced any additional symptoms/events.  It was unknown if there were lab data/results available.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was unknown for the reported event.  There will be no information available on the batch number for this case.
It was reported in a published article, title as stated above that  a 10.5 month-old patient who was born prematurely, had a true vaccination failure (TVF) developed invasive Hib disease, also referred as meningitis, only 11 days after receipt of vaccine. The patient had been vaccinated with a first dose of PEDVAXHIB (manufacturer unknown) at 1.4 months of age, the patient was given a second dose of Hib conj vaccine (manufacturer unknown) at 5.4 months of age and a third dose of Hib conj vaccine (manufacturer unknown) was given 11 days before the illness. No further information was available at the time of this report. No outcome information was reported. upon internal review, invasive Hib disease/meningitis was determined to be an other important medical event. Additional information has been requested.
I was preparing a Boostrix and  a Shingrix each for a married couple. On the second Shingrix I recapped the needle after drawing up the adjuvant to stop and put a phone call on hold. I then forgot to mix the adjuvant in the antigen and administered the shot. Because I took all shots out at the same time and I can not see the shot booth from the cameras I am not sure which patient got the shot that did not have the adjuvant. I noticed the mistake when I was about to throw the vials in the sharps after administration and noticed one of the vials was white. no harm to patient.
Fever (100 F), severe vomiting, nausea, ringing in ears/tinnitus, joint pain, headache, mental confusion, chills, and uncontrollable jerking/shaking movements.
PNEUMOVAX had a large redness and swelling where shot given. SHINGRIX was tender but not as much. Then rash on both thighs itchy rash.
administered expired dose at 17 hours and 35 minutes; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered expired dose at 17 hours and 35 minutes) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0939901 and 023D21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Aug-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (administered expired dose at 17 hours and 35 minutes). On 26-Aug-2021, EXPIRED PRODUCT ADMINISTERED (administered expired dose at 17 hours and 35 minutes) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant product information was provided.  Treatment information was not provided.
Vaccine given at 0824 on 11/15/12 in (R) deltoid at about 10 am pt started getting sore arm & redness at site at about 3pm pt presented back to clinic with painful, swollen (R) deltoid, limited ROM (90 degrees abduction). Treated with ice/TYLENOL good relief of pain still limited ROM VSS: 131/95 T-99.6 P 100. Sent home with ice pack, TYLENOL, MOTRIN.
This is a 68 y.o. female who presents to Hospital ER due to altered mental status.  The patient reports that she was speaking to a friend on the phone and she developed difficulty speaking for about 5 minutes.  Her speech difficulty spontaneously resolved.  She has been undergoing evaluation for headaches as an outpatient and has seen neurology previously.  She was scheduled to have an MRI performed in the coming week.  In the ER she had a CT of the brain with stroke protocol which was negative for acute process.  She has been admitted for further evaluation and treatment.  Cardiology has evaluated her for uncontrolled hypertension and 2-1 AV block.  She is taking Toprol-XL at home which is felt to be a contributing factor.  Cardiology has stopped her beta-blocker and she is being monitored.  A pacemaker will be needed if her second-degree heart block persists.   Additionally she is found to be positive for COVID-19.  She is vaccinated x2
difficulty of breathing after first dose; he's been having insomnia.; felt nauseous; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DYSPNOEA (difficulty of breathing after first dose), INSOMNIA (he's been having insomnia.) and NAUSEA (felt nauseous) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Aug-2021, the patient experienced DYSPNOEA (difficulty of breathing after first dose), INSOMNIA (he's been having insomnia.) and NAUSEA (felt nauseous). At the time of the report, DYSPNOEA (difficulty of breathing after first dose), INSOMNIA (he's been having insomnia.) and NAUSEA (felt nauseous) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were reported. No treatment medication were reported.   Reporter did not allow further contact
Patient complains of left arm swelling at injection site and tenderness. Dx-Adverse effect of Influenza vaccine, micial encanter. Ibuprofen as needed for swelling and pain, cool compress, Recheck as needed for persistence, worsening or appearance of new symptoms.
Felt drowsy; Headache; Body ache; Muscle aches; Breathing was to the point where had to take deep breaths; Felt weak in his legs; Soreness in his arms; Missing Second Dose of the Vaccine Today; This is a spontaneous report from a contactable consumer or other non-HCP (Patient). A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), dose 1, via an unspecified route of administration on 24Mar2021 as single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. After taking the first dose, patient was feeling fine until 10-15 days later, he felt drowsy, headache, body ache, muscle aches, and his breathing was to the point were had to take deep breaths on an unspecified date. Caller stated his next vaccine was scheduled for today and he was still feeling body aches, even just leaving his arm in the air to hold the phone, he felt the body aches. He was really looking forward to getting his second shot but when he woke up today, he still felt weak in his legs, had a headache and soreness in his arms on an unspecified date. The patient missing second dose of the vaccine today. The outcome of events was unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
100.3 temp; tired; big breakout; rash in same area but not injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (big breakout), RASH (rash in same area but not injection site), PYREXIA (100.3 temp) and FATIGUE (tired) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. #007H20A and #042L20A) for COVID-19 vaccination.     The patient's past medical history included Hypersensitivity, Asthma in 1955 and Urticaria. Previously administered products included for an unreported indication: SMALLPOX VACCINE (Reactions include itchy left arm for 12 months.) in 1976. Concurrent medical conditions included Allergic reaction to antibiotics (Penicillin -reactions include rash after 10 days.) and Allergic reaction to drug (Codeine - reactions include red cheeks). Concomitant products included albuterol nebs, MONTELUKAST SODIUM (SINGULAIR), FLUTICASONE FUROATE, VILANTEROL TRIFENATATE (BREO ELLIPTA) and TIOTROPIUM BROMIDE (SPIRIVA) for Asthma, ATORVASTATIN CALCIUM (LIPITOR) for Cholesterol, benecar, DENOSUMAB (PROLIA) and mylaanta for an unknown indication.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Feb-2021, the patient experienced VACCINATION SITE REACTION (big breakout) and RASH (rash in same area but not injection site). On an unknown date, the patient experienced PYREXIA (100.3 temp) and FATIGUE (tired). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) (oral) on 28-Jan-2021 for Allergy, at an unspecified dose and frequency and CLOBETASOL PROPIONATE from 28-Jan-2021 to 05-Feb-2021 for Allergy, at an unspecified dose and frequency. On 16-Feb-2021, VACCINATION SITE REACTION (big breakout) had resolved. At the time of the report, RASH (rash in same area but not injection site), PYREXIA (100.3 temp) and FATIGUE (tired) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the events was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 17-May-2021: Hypersensitivity form
Second shot being administered and 1 ml was given but it should have been 0.5 ml.  She denies any symptoms at this time.
Information has been received from a physician concerning a 15 month old patient who on unspecified dates was vaccinated with all three doses of ROTATEQ (lot number and route not reported). Subsequently the patient experienced dehydration and tested positive for rotavirus and was hospitalized. At the time of the report, the patient's status was unknown. Dehydration and positive for rotavirus were considered to be disabling. This is one of several reports received from the same source. Additional information has been requested.
Pt experienced warmth at injection site, redness, and knot. Subsided after 5-7 days with continued improvement - no physician appt required.
Pt is a 55 y.o. male who presents with Acute respiratory distress syndrome (ARDS) due to 2019 novel coronavirus (CMS/HCC)   Pulmonary:     Effort: He is intubated.     Breath sounds: Decreased breath sounds and rhonchi present.     Comments: On mechanical ventilation and ecmo  (Principal) Pneumonia due to 2019 novel coronavirus  Initially tested positive for Covid on 8/3 Intubated and cannulated for VV ECMO on 8/20 Bivent w/ 50% FiO2; ECMO 100%, sweep 4 On Veletri: ECHO EF 60-80%, RV mildly dilated, fxn normal Wean settings as able Continue q4hr and PRN ABG's CXR as needed Continue diuresis with lasix drip  Patient presented as a transfer for management of Covid pneumonitis with ECMO.   He was supported for a short time,  But 6 days later a CT of the Brain revealed multiple intracranial hemorrhages with midline shift.  With these findings, comfort measures were undertaken, and he expired shortly after that.
Patient did not suffer any reactions due to vaccine, but was given the vaccine in the upper arm/shoulder area with resulting pain and decreased ROM.
adverse reaction after his Moderna booster; fri-sat - aching in every joint, sun until today- he is fine; 1st and 2nd dose Pfizer and Moderna booster dose; This spontaneous case was reported by a consumer and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (1st and 2nd dose Pfizer and Moderna booster dose), VACCINATION COMPLICATION (adverse reaction after his Moderna booster) and ARTHRALGIA (fri-sat - aching in every joint, sun until today- he is fine) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: PFIZER BIONTECH COVID-19 VACCINE (Dose 2) and PFIZER BIONTECH COVID-19 VACCINE (Dose 1). Past adverse reactions to the above products included No adverse event with PFIZER BIONTECH COVID-19 VACCINE and PFIZER BIONTECH COVID-19 VACCINE.    On 18-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Nov-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (1st and 2nd dose Pfizer and Moderna booster dose). On 19-Nov-2021, the patient experienced ARTHRALGIA (fri-sat - aching in every joint, sun until today- he is fine). On an unknown date, the patient experienced VACCINATION COMPLICATION (adverse reaction after his Moderna booster). On 18-Nov-2021, INTERCHANGE OF VACCINE PRODUCTS (1st and 2nd dose Pfizer and Moderna booster dose) had resolved. On 20-Nov-2021, ARTHRALGIA (fri-sat - aching in every joint, sun until today- he is fine) had resolved. At the time of the report, VACCINATION COMPLICATION (adverse reaction after his Moderna booster) outcome was unknown.            Concomitant medications and treatment medications were not provided by reporter.  Patient had aching in every joint from Fridayto Saturday and Sunday to 23-Nov-2021, patient was fine.
(1) Patient notes arm swelling, redness, discomfort, difficulty moving arm, also notes headache & flare of SVT --> 2/11/13 - started Z-PACK, EKG done & stable.
This patient was hospitalized with cardiac valve thrombosis within 5 days of being administered the 3rd booster immunization. patient was then put on a heparin infusion to manage the thrombosis and then proceeded to develope a 15mm subdural hematoma.
coughing; Soreness; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (coughing) and ARTHRALGIA (Soreness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no historical condition was reported).    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced ARTHRALGIA (Soreness). On 14-Jan-2021, the patient experienced COUGH (coughing). At the time of the report, COUGH (coughing) and ARTHRALGIA (Soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Patient presented with sudden onset of copious emesis, unusual watery green stool, lethargy. In emergency department, was tachycardic and hypotensive with concern for sepsis or acute abdominal process.  Received IV fluids and IV antibiotics and was admitted to the hospital for observation.  Cultures remained negative and there was high clinical suspicion for intussusception.
This is a spontaneous report from a non-contactable nurse. A 29-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, batch/lot number and expiration date unknown), intramuscular the first dose on arm left on 23Dec2020 09:00 am, the second dose on right arm on 14Jan2021 09:00 am, both at single dose for covid-19 immunisation. The patient medical history was not reported.  Concomitant medication included ibuprofen (MOTRIN [IBUPROFEN]). The patient experienced pain injection site, fever of 102.2, malaise, all on an unspecified date with outcome recovered. Therapeutic measures were taken as a result of pain at injection site. The patient underwent lab tests and procedures which included Covid test with nasal swab: negative on 16Jan2021. The patient is not pregnant. No follow-up attempts are possible. No further information is expected.
Patient received first dose of Pfizer vaccine on 07/27/2021, then she received second dose on 08/17/2021, and then she received a third dose of the same vaccine on 08/20/2021.   The patient had mild heart problems , such as palpitations and higher heart rate after the second dose.  The patient  came in to the pharmacy and, by mistake, she received a third dose.   We called the manufacture (Pfizer), and the CDC, and they recommended counseling the patient to avoid another dose of Vaccine, rest at home, and observe signs of major problems with her heart.  In case of a major heart problem, she should go to an emergency room to get an appropriate treatment.
Redness, swelling, heat, inflammation, and pain with movement or touch at the injection site. Nausea, vomiting, low fever (100.5), body aches and pains (random muscles having strong pains at different times), headache, all skin hurt to touch, similar to a sunburn. 11 days after and injection site is still swollen and appears to be bruised.